Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over-the-counter drug and device products, cosmetics, and supplement products primarily focusing on general wellness, sexual health and wellness, skincare, and hair care. In addition, the company's curated non-prescription products include melatonin and biotin in the wellness specialty category; moisturizers, creams, sunscreen, serum, face oil, and face wash in the skincare specialty; condoms, climax delay spray and wipes, vibrators, and lubricants in the sexual health and wellness specialty; and shampoos, conditioners, scalp scrubs, and topical treatments, such as minoxidil in the hair care specialty category. Further, it offers medical consultation and post-consultation support services, as well as health and wellness products through wholesale partners. Hims & Hers Health, Inc. is based in San Francisco, California.

Hims & Hers Health Inc. Class A

Analysts fell to the sidelines weighing in on AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF) and Hims & Hers Health (HIMS) with neutral ratings, i...

Analysts’ Top Healthcare Picks: AbbVie (ABBV), Takeda Pharmaceutical Co (TKPHF)

Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS...

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Meiragtx Holdings (MGTX), Hims & Hers Health (HIMS) and Siemens Healthineers AG (OtherSEMHF)

Low-cost healthcare services provider Hims & Hers ($HIMS) on Thursday disclosed the availability of approved versions of Novo Nordisk’s ($NVO) GLP-...

HIMS Stock Slides after Wegovy Subscription Launch; BofA Sees 31% Drop in GLP-1 Franchise

Analysts are intrested in these 5 stocks: ( ($HIMS) ), ( ($NVO) ), ( ($CRWD) ), ( ($SEDG) ) and ( ($TU) ). Here is a breakdown of their recent


Hims, Novo, CrowdStrike, SolarEdge, Telus Trending With Analysts

Shares of Hims & Hers Health ($HIMS) rose 6% in pre-market trading, extending a 58% gain over the past five days. The rally followed a deal with No...

Hims & Hers (HIMS) Stock Rallies 58% in Five Days — Can the Momentum Last?

Hims & Hers Health ( ($HIMS) ) has shared an announcement. On March 9, 2026, Hims & Hers announced a strategic overhaul of its U.S. weight-loss bus...

Hims & Hers revamps GLP-1 strategy with Novo Nordisk

Hims & Hers ($HIMS) shares have been on a tear, up 49% since announcing a deal to sell Novo Nordisk’s ($NVO) weight-loss drugs Wegovy and Ozempic o...

HIMS-Novo ‘Can’t Quit Each Other’ – Bulls Rally on Wegovy Deal

Hims & Hers Health ($HIMS) is getting a wave of bullish attention from Wall Street after the telehealth company and Novo Nordisk ($NVO) resolved th...

Needham Upgrades Hims & Hers Stock (HIMS) after Novo Nordisk Deal Resets Weight Loss Outlook

Investors seeking the top stock market stories for Monday will want to check out the daily wrap-up.


Morning News Wrap-Up 3/9/26: Monday’s Biggest Stock Market Stories!

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on NovaBridge Biosciences (NBP – Research Report) and H...

	A	B	C	D
1	Symbol	Price	Change	Volume
2	HIMS	$19.13	-1.92%	16.92M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	HIMS	$19.13	-1.9%	16.92M
3
4
5
6

HIMS

HIMS

No Data Available

Get Hims & Hers Health Inc. Class A Data in Excel

Get Hims & Hers Health Inc. Class A Data in Excel